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Abstract: Understanding how age affects fertility becomes increasingly relevant as couples delay
childbearing toward later stages of their lives. While the influence of maternal age on fertility is well
established, the impact of paternal age is poorly characterized. Thus, this study aimed to understand
the molecular mechanisms responsible for age-dependent decline in spermatozoa quality. To attain it,
we evaluated the impact of male age on the activity of signaling proteins in two distinct spermatozoa
populations: total spermatozoa fraction and highly motile/viable fraction. In older men, we observed
an inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) in the highly viable
spermatozoa population. On the contrary, when considering the entire spermatozoa population
(including defective/immotile/apoptotic cells) our findings support an active mTORC1 signaling
pathway in older men. Additionally, total spermatozoa fractions of older men presented increased
levels of apoptotic/stress markers [e.g., cellular tumor antigen p53 (TP53)] and mitogen-activated
protein kinases (MAPKs) activity. Moreover, we established that the levels of most signaling proteins
analyzed were consistently and significantly altered in men older than 27 years of age. This study
was the first to associate the mTOR signaling pathway with the age impact on spermatozoa quality.
Additionally, we constructed a network of the sperm proteins associated with male aging, identifying
TP53 as a central player in spermatozoa aging.
Keywords: aging; sperm quality; signaling proteins; mTORC1; TP53
1. Introduction
Infertility is a growing concern in modern societies, especially in industrialized countries where
birth rates are declining drastically below replacement levels [1]. Infertility affects approximately 15%
of couples attempting to conceive and, in half of the cases, the cause is related to male reproductive
issues [1]. Moreover, idiopathic infertility remains the most common type of male infertility [2,3].
The trend in parenthood at an older age is increasingly more pronounced, with the age of first
child averaging 30 years in several countries [4]. In addition to intentionally delayed childbearing
due to professional activities, increased rates of obesity, sedentary lifestyle, and alcohol and nicotine
Cells 2019, 8, 629; doi:10.3390/cells8060629 www.mdpi.com/journal/cells
Cells 2019, 8, 629 2 of 13
consumption found in reproductive-aged men and women further perpetuate the problem. While it is
well documented that women have a decline in fecundity with age [5], the studies available regarding
the effects of age on male fertility have a wider disparity of results. Most studies are mainly focused
on basic semen parameters and DNA integrity [6]. Most of these studies reported lower semen
volume, sperm concentration, sperm motility, and proportions of sperm of normal morphology in
older men; still, some found semen quality to be independent from age or even reported improvements
in semen traits [6,7]. Additionally, most studies are limited to a specific study population and are
influenced by the female partner age [7,8]. Stone et al. reported that basic seminal parameters start to
decline at 34 years of age [9]. Numerous studies described adverse associations between male age and
reproductive outcomes. Advanced paternal age was associated with lower pregnancy rates, higher
risk of pregnancy loss, and a broad range of developmental, morphologic and neurologic disorders of
the newborn, including schizophrenia, autism, X-linked recessive and autosomal dominant disorders,
trisomy, and some cancers [6,7,10–12]. While the molecular mechanisms are still not understood, aging
is associated with an increase in oxidative stress, and a decline in sperm quality was correlated with
the excessive generation of reactive oxygen species (ROS) [6].
Since the molecular mechanisms responsible for age-dependent decline in spermatozoa quality
are not fully understood, in this study, we evaluated the impact of aging on human spermatozoa
signaling pathways, including the mitogen-activated protein kinases (MAPKs), the mechanistic target
of rapamycin (mTOR), and the apoptosis signaling pathways. Given the heterogeneous nature of
the ejaculate in terms of sperm integrity/functionality, two distinct spermatozoa populations were
analyzed: total spermatozoa fractions and highly motile/viable fractions. Additionally, we determined
whether age thresholds for the signaling proteins examined existed. An interaction network of the
sperm proteins associated with male age was constructed and analyzed.
2. Material and Methods
2.1. Ethical Approval
This study was approved by the Ethics and Internal Review Board (Process number: 36/AO) of the
Hospital Infante D. Pedro E.P.E., Aveiro, Portugal and was conducted in accordance with the ethical
standards of the Helsinki Declaration. All participants received clear written instructions concerning
sample collection, study design, and signed informed consent, allowing the samples to be used for
scientific purposes. No monetary compensation was applied. All data were anonymized.
2.2. Study Design
Given the heterogeneous nature of the ejaculate in terms of sperm integrity/functionality,
two distinct populations were analyzed: total spermatozoa fractions and highly motile/viable fractions.
A total of 93 human semen samples were included in this study from volunteers randomly
assigned to one of the two cohorts. The dataset included both volunteers recruited at the University of
Aveiro (Aveiro, Portugal) and men providing semen samples for routine analysis at Hospital Infante D.
Pedro, E.P.E. (Aveiro, Portugal) and at COGE Obstetric and Gynecological Clinic of Espinho (Espinho,
Portugal). Exclusion criteria comprised varicocele, genital tract infection, cryptorchidism and testicular
trauma, systemic illness, and use of any medications.
2.3. Semen Analysis and Processing
Semen samples were obtained by masturbation into a sterile container and delivered for basic
semen analysis within 30 min. All samples were analyzed according to the World Health Organization
criteria by experienced technicians [13].
Semen samples were processed using either a simple wash method or a density gradient
centrifugation followed by swim-up. In the simple wash method, after complete liquefaction, 1×
phosphate-buffered saline (PBS) was added to the ejaculate and centrifuged (5 min at 500× g) twice
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to remove the seminal plasma. Spermatozoa were subsequently used for the antibody array. It is
worth noting that samples were thoroughly scanned for the presence of somatic cells (including
leucocytes) and only samples that did not contain somatic cells were subjected to this washing method.
This analysis was performed according to the World Health Organization guidelines [13] by examining
a stained smear at 1000× magnification.
For the density gradient centrifugation, semen was centrifuged with gradients SupraSperm
(company, Origio, Denmark) at 55% and 80%, for 20 min at 300× g. The supernatant was
carefully aspirated, and the sperm pellet was resuspended and washed with Sperm Preparation
Medium (CooperSurgical Fertility & Genomic Solutions, Malov, Denmark) for 10 min at 300× g.
Sperm Preparation Medium (company) was carefully added above the pellet and incubated at a 45◦
angle for 1 h for swim-up in a vertical rack in a 37 ◦C incubator. Spermatozoa were subsequently used
for the antibody array.
For the antibody array, spermatozoa were incubated with 1×PathScan Sandwich ELISA Lysis Buffer
(Cell Signaling Technology, Danvers, MA, USA) supplemented with 1 mM phenylmethanesulfonyl
fluoride (PMSF) for 5 min on ice. Then, the lysed cells were centrifuged at 14,000× g at 4 ◦C for 10 min,
and the supernatant was transferred to a new tube and stored at −80 ◦C.
2.4. Protein Quantification
Protein concentration was measured using a bicinchoninic acid assay (Pierce BCA Protein Assay
Kit, Thermo Fisher Scientific, Waltham, MA, USA), and final absorbance was measured at 562 nm in a
microplate reader (Infinite® 200 PRO series, Tecan Trading AG, Mannedorf, Switzerland).
2.5. Antibody Array
Antibody-based arrays were carried out using the PathScan® Intracellular Signaling Array Kit
(#7744, Cell Signaling Technology) to determine the expression patterns of 18 well-characterized
signaling molecules when phosphorylated or cleaved, in 93 semen samples. Sixty-three spermatozoa
samples were analyzed using extracts prepared by the simple wash method, and 30 samples were
prepared with gradient density centrifugation followed by swim-up.
The Intracellular Signaling Array Kit allows simultaneously detecting multiple molecules from a
wide range of key signaling pathways for mammalian cells including the MAPK, mTOR, and apoptosis
signaling pathways.
Each cell extract was diluted to 250 µg/mL and applied to its own multiplexed array according to
the manufacturer’s instructions. Fluorescence readouts from the arrays were captured digitally using
LI-COR® Biosciences Odyssey® imaging system (LI-COR® Biosciences, City, NE, USA). Pixel intensity
was quantified using Odyssey software. The intensity from the negative control (without an antibody
captured onto the array) within each array was subtracted from all signals, and all data from each
array were normalized to the internal positive control within each array.
2.6. Network and Bioinformatics Analysis
A literature search was conducted using the PubMed database to identify human sperm proteomic
studies, including proteins differentially expressed between young adults and aged men. By merging
data from the available papers, a list of 7622 different proteins present in human spermatozoa was
created (30 April 2018).
The testis/sperm-enriched/specific proteins were extracted from the Human Protein Atlas (HPA)
dataset [14], and a list of 2237 different proteins was extracted (27 February 2018).
The Human Integrated Protein-Protein Interaction rEference (HIPPIE) database was used for
retrieving human protein–protein interaction (PPI) data (23 April 2018). This database is regularly
updated by incorporating interaction data from major expert-curated experimental PPI databases [15].
The protein network was built using Cytoscape V3.5.1 software (Institute for Systems Biology, Seattle,
WA, USA) [16].
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Functional enrichment analysis of Gene Ontology categories was performed using the Panther
overrepresentation test. The overall set of human protein-coding genes was used as reference set,
and only enriched functions with p < 0.05 (including Bonferroni correction) were considered.
Protein identities associated with defects in male fertility or a functional/morphological defect in
the male reproductive system were obtained from the DisGeNET database [17] and the Mouse Genome
Informatics (MGI) database [18].
2.7. Statistical Analysis
We performed an observational study of a cohort of 93 healthy men. Initially we conducted an
exploratory data analysis (EDA) using graphical techniques and quantitative analysis to characterize
the sample, and to detect possible extreme outliers and measurement errors. Quantitative variables
were firstly checked for normality using Shapiro–Wilk tests together with an inspection of their
graphical representation.
We evaluated the impact of male age on the activity of signaling proteins in two
distinct spermatozoa populations: total spermatozoa fraction and highly motile/viable fraction.
Correlations between age and the expression of signaling proteins were evaluated using Pearson’s
correlation coefficient. In the total spermatozoa fraction population, for the variables with at least
moderate correlation, the power of age as a predictor of change of the molecular parameters was
quantified by the area under the Receiver Operating Characteristic (ROC) curve (AUC) (assuming a
parameter change when greater than or equal to mean ± SD). When the area under the ROC curve was
significantly higher 0.7, we calculated the cutoff (age) applying Youden’s index. This technique did not
allow determining age thresholds in the highly motile/viable spermatozoa fraction, since the area under
the curve was not significant. After this exploratory analysis, to investigate the existence of differences
in molecular parameters after 27 years (cutoff previously found), we conducted Mann–Whitney U
tests. The assumptions of the statistical techniques used were validated. The statistical analysis was
performed using IBM-SPSS version 21 for Windows (IBM Corp, Armonk, NY, USA). A significance
level of 0.05 was adopted.
3. Results
3.1. Age Impacts the Activity of Several Signaling Proteins
The levels of 18 signaling proteins in distinct status of activation were determined in human
spermatozoa using an antibody array which allowed analyzing a wide range of key signaling pathways
for mammalian cells including the MAPK, mTOR, and apoptosis signaling pathways (Table S1,
Supplementary Materials).
A total of 63 spermatozoa samples were analyzed using extracts prepared by a simple wash
method, which allowed the recovery of all spermatozoa populations, rather than a sperm subpopulation
(Table S2, Supplementary Materials). The volunteers’ ages ranged from 18 to 47 years (mean ± SD = 26
± 7), and only seven were smokers. It is worth noting that the 63 men included in this dataset did not
undergo assisted reproduction technology (ART) due to male factor. The results indicated that the
levels of several phosphoproteins in human spermatozoa were positively correlated with age: cellular
tumor antigen p53 (TP53) (S15), Bcl2-associated agonist of cell death (BAD) (S112), MAPK14/11/12/13
(T180/Y182), MTOR (S2448), Proline-rich AKT1 substrate 1 (AKT1S1) (T246), heat shock protein
beta-1 (HSPB1) (S78), RAC-alpha serine/threonine-protein kinase (AKT) (S473), Glycogen synthase
kinase-3 beta (GSK3B) (S9), MAPK8 (T183/Y185), and 40S ribosomal protein S6 (RPS6) (S235/236).
The cleavage and consequent activation of Caspase-3 (CASP3) (D175) was also positively correlated
with age (Table 1; Table S3, Supplementary Materials).
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Table 1. Pearson’s correlation coefficients between age and the activity patterns of signaling proteins in
human spermatozoa.
Uniprot ID
Abbreviation
Protein Name
Phosphorylation/Cleavage,
Residue, Status
Pearson’s Correlation
CoefficientFormerly Presently
Total Spermatozoa Populations
P04637 p53 TP53 Cellular tumor antigen p53 Phospho S15 Activation 0.451 **
Q92934 Bad BAD Bcl2-associated agonist ofcell death Phospho S112 Inhibition 0.434 **
Q16539
p38 MAPK
11/12/13/14
Mitogen-activated protein
kinase 14/11/12/13
Phospho
T180/Y182 Activation 0.430 **
Q15759
P53778
O15264
P42345 mTOR MTOR Serine/threonine-proteinkinase mTOR Phospho S2448 Activation 0.409 **
Q96B36 PRAS40 AKT1S1 Proline-richAKT1 substrate 1 Phospho T246 Inhibition 0.406 **
P04792 HSP27 HSPB1 Heat shock protein beta-1 Phospho S78 Activation 0.373 **
P31749 Akt AKT
RAC-alpha
serine/threonine-protein
kinase
Phospho S473 Activation 0.365 **
P42574 Caspase-3 CASP3 Caspase-3 Cleavage D175 Activation 0.362 **
P49841 GSK-3β GSK3B Glycogen synthasekinase-3 beta Phospho S9 Inhibition 0.354 **
P45983 SAPK/JNK MAPK8 Mitogen-activated proteinkinase 8
Phospho
T183/Y185 Activation 0.335 **
P62753 S6 ribosomalprotein RPS6 40S ribosomal protein S6
Phospho
S235/236 Activation 0.317 **
Highly Motile/Viable Spermatozoa
Q96B36 PRAS40 AKT1S1 Proline-richAKT1 substrate 1 Phospho T246 Inhibition −0.523 **
P23443 p70 S6 kinase RPS6KB1 Ribosomal proteinS6 kinase beta Phospho T389 Activation −0.382 *
* Correlation is significant at the 0.05 level (two-tailed); ** correlation is significant at the 0.01 level (two-tailed).
To determine whether age thresholds existed, the area under the ROC curve (AUC) was analyzed
for each molecular parameter. It was established that the levels of most signaling proteins were analyzed
consistently and significantly increased after 27 years of age (AUC greater than 0.726, sensibility greater
than 88%, and specificity greater than 69%) (Figure S1, Table S4, Supplementary Materials). In fact,
the levels of all signaling proteins found to be associated with age were significantly increased in the
population aged 27 or more (Table S4, Supplementary Materials), most of which were associated with
the mechanistic target of rapamycin (MTOR) signaling cascade (Figure 1).
Cells 2019, 8, 629 6 of 13
Cells 2019, 8, x 6 of 12 
 
 
Figure 1. Signaling proteins associated with the mechanistic target of rapamycin (MTOR) pathway 
differentially activated between groups aged ≤27 and aged >27. Results are expressed as mean ± SEM. 
The difference between groups was assessed by Mann–Whitney U test. * Difference is significant at the 
0.05 level (two-tailed); ** difference is significant at the 0.01 level (two-tailed). 
To evaluate the levels of the signaling molecules in highly motile, morphologically normal, 
viable spermatozoa, a total of 30 semen samples were prepared with gradient density centrifugation 
followed by swim-up (Table S5, Supplementary Materials). It is worth noting that, from the 30 men, 
only one resorted to ART due to male factor (no pregnancy was achieved), and only five were 
smokers. Ages ranged from 18 to 46 years (mean ± SD = 37 ± 7). In the motile/viable spermatozoa 
population, the levels of two phosphoproteins were negatively correlated with age: AKT1S1 (T246) 
and RPS6KB1 (T389) (Table 1; Table S3, Supplementary Materials). Given the relatively small sample 
size in this group (N = 30), it was not possible to determine an age threshold. Nevertheless, when 
considering the age threshold identified previously and despite only three volunteers being below 
that age cutoff, the levels of inhibited AKT1S1 and activated MAPK8 (both associated with the MTOR 
pathway) were significantly decreased in men aged over 27 years old (Figure 1; Table S4, 
Supplementary Materials). 
3.2. Network of Sperm Proteins Associated with Male Age 
A protein–protein interaction (PPI) network was constructed based on information gathered 
from the proteins identified in this study (green nodes, Table 1) and from proteins identified from 
the literature search (pink and blue nodes, Table S5, Supplementary Materials) whose activity or 
expression, respectively, was associated with male age (Figure 2). 
Figure 1. Signaling proteins associated with the mechanistic target of rapamycin (MTOR) pathway
differentially activated between groups aged ≤27 and aged >27. Results are expressed as mean ± SEM.
The difference between groups was assessed by Mann–Whitney U test. * Difference is significant at the
0.05 level (two-tailed); ** difference is significant at the 0.01 level (two-tailed).
To evaluate the levels of the signaling molecules in highly motile, morphologically normal, viable
spermatozoa, total of 30 semen samples were prepared with gradient density centrifu ation followed
by swim-up (Table S5, Supplementary Materials). It is worth noting that, from the 30 men, only
one resorted to ART due to male factor (no p egn ncy was achieved), and only five were smok rs.
Ages ranged f om 18 to 46 years (mean ± SD = 37 ± 7). In the motile/viable spermatozoa population,
the levels of two phosphoproteins were negatively correlated with age: AKT1S1 (T246) and RPS6KB1
(T389) (Table 1; Table S3, Sup lementary Materials). Given the relatively small sample size in this
group (N = 30), it was not possible to determine an age thr shold. Neverthel ss, when considering
the age t resh ld identified previously and despite only thre volunteers being below that age cutoff,
the lev ls of inhibit d AKT1S1 and act vated MAPK8 (both a sociated with the MTOR pathway) were
significantly decr ased in men aged over 27 years old (Figure 1; Table S4, Supplementary Materials).
3.2. Network of Sperm Proteins Associated with Male Age
A protein–protein interaction (PPI) network was constructed based on information gathered
from the proteins identified in this study (green nodes, Table 1) and from proteins identified from
the literature search (pink and blue nodes, Table S5, Supplementary Materials) whose activity or
expression, respectively, was associated with male age (Figure 2).
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Figure 2. Network of the sperm proteins differentially associated with male age. Green nodes represent
the proteins identified in this study whose activity is correlated with age. Pink and blue nodes represent
the proteins gathered from the literature search that are upregulated or downregulated in older men,
respectively. Red outline represents testis-enriched/specific proteins. Node sizes represent the relative
degree of the nodes.
The total number of proteins in the PPI network was N = 39 and the total number of interactions
between them was L = 68. Nine proteins from the dataset had no PPI data available (isolated nodes).
In Figure 2, node size is proportional to the number of interactions of each node (k, degree). TP53 (k =
15), AKT1 (k = 13), MTOR (k = 10), GSK3B (k = 8), MAPK8 (k = 8), 14-3-3 protein theta (YWHAQ)
(k = 7), and myosin-9 (MYH9) (k = 6) were the proteins with a higher degree of connectivity in the
network. The average number of neighbors in the network was 4.533. Proteins identified in this study
(green nodes) and proteins gathered from the literature search (pink and blue nodes) were highly
interconnected. The mean clustering coefficient was C = 0.311. The clustering coefficient characterizes
how the nearest neighboring nodes of a node are connected to each other. If all of them are tightly
connected to each other, then they form a clique and the clustering coefficient is 1. For a sparse
random uncorrelated network of finite size N, this coefficient is close to zero. Note that the value C =
0.311 is about 16 times larger than the clustering coefficient expected for a sparse random uncorrelated
network (in the latter case, C = <q>/N~0.02). When analyzing only the proteins identified by Liu and
colleagues [19] as differentially expressed in aged men (blue and pink nodes) and the interactions
between them, the clustering coefficient of the network was C = 0.00. Among the proteins identified by
Liu and colleagues [19], the enrichment analysis revealed that the only biological process category
displaying p < 0.05 was protein folding (heat shock-related 70 kDa protein 2 (HSPA2), T-complex protein
1 subunit gamma (CCT3), and T-complex protein 1 subunit eta (CCT7); p = 2.89 × 10−2), with a fold
enrichment of 31.98 (expected = 0.09). When considering all the proteins in the network, the significant
biological processes were protein folding, MAPK cascade, phosphate-containing compound metabolic
process, and response to stimulus (Table S7, Supplementary Materials).
The PPI network was then expanded by adding the interactors annotated in the Gene Ontology
category “aging” (Figure S2, Supplementary Materials). In total, 286 proteins were annotated in
Homo sapiens in this category and, from those, 122 were interactors of the proteins in Figure 2.
The total number of proteins in the network was N = 161 and the total number of interactions between
them was L = 446. The mean clustering coefficient of the network was C = 0.225 and the average
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number of neighbors 5.682, with only four isolated nodes. The proteins with a higher degree of
connectivity in this network were TP53 (k = 73), HSPA4 (k = 37), AKT1 (k = 36), YWHAQ (k = 28),
MAPK8 (k = 27), GSK3B (k = 24), and MYH9 (k = 22). The enrichment analysis revealed that the
most significant biological processes were response to stress, apoptotic process, MAPK cascade, DNA
repair, regulation of cell cycle, and protein folding (Table S8, Supplementary Materials). Ninety-one
proteins from the network were previously reported in human spermatozoa proteomes and eight are
testis/sperm-enriched/specific proteins.
4. Discussion
Several studies investigated the age-based impact on semen parameters, such as semen volume,
sperm concentration, morphology, motility, and DNA fragmentation [6–8], but the impact of paternal
age on human spermatozoa signaling pathways remains unknown.
The heterogeneous nature of the ejaculate in terms of sperm integrity/functionality makes it crucial
to characterize distinct populations. To that end, total spermatozoa and highly motile/viable fractions
were analyzed to determine the association of male age and the activity patterns of key signaling
proteins in human spermatozoa.
In this study, the activity of 12 proteins in spermatozoa was correlated with male age. From those,
half were main components of the mTORC1 signaling pathway (Table 1, Figure 3).
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Figure 3. mTOR signaling in spermatozoa from older men. In older men, we observed an inhibition of
mTORC1 in the highly viable spermatozoa population. On the c ntrary, when considering the entire
sper atozoa population (including defective, immotile, apoptotic cells), all our findings support an
active mTORC1 signaling pathway. Red reflects the findings of this study.
Mechanistic target of rapamycin (mTOR) functions in two distinct complexes, mTORC1 and
mTORC2 [20]. mTORC1 has five components: MTOR, which is the ca aly i subunit of the complex;
RAPTOR (regulatory-associated pr tein of MTOR); MLST8 (target of rapamycin complex subunit
LST8); and two inhibitory ubunits AKT1S1 (proline-rich AK 1 substrate 1, also known as PRAS40) and
DEPTOR (DEP domain containing mTOR interacting p otein). RPS6KB1 (ribosomal protein S6 kinase
beta-1, also known as p70S6 kinase) is a major subs rate of mTORC1. Phosphorylati n of AKT1S1 by
AKT1 at T246 releases AKT1S1 from the mTORC1 complex leading t the binding of phosphorylated
AKT1S1 to cytoplasmic docking protein 14-3-3 (YWHA), thereby abolishing the inhibitory effect of
AKT1S1 n mTORC1 signaling [20].
Cells 2019, 8, 629 9 of 13
In this study, the levels of inhibited AKT1S1 and activated RPS6KB1 were reduced in highly
motile/viable spermatozoa of older men, which reflects an inhibition of mTORC1 signaling in this
spermatozoa population (Figures 1 and 3). Conversely, in the total spermatozoa fraction of older men,
the levels of phosphorylated AKT1, AKT1S1, mTOR, and RPS6 were increased, reflecting an activation
of the mTORC1 signaling (Figures 1 and 3). Additionally, we showed that activated MAPK8 is increased
in the total spermatozoa fraction and decreased in the highly motile/viable spermatozoa, which is
consistent with mTORC1 activation and inhibition, respectively (Figure 3). MAPK8 was described
to phosphorylate RAPTOR in stress conditions [21]. RAPTOR phosphorylation normally promotes
mTORC1 activity and signaling to downstream substrates [22].
Although there is a consensus that mTOR signaling plays a key role in mammalian aging,
the mechanism through which this occurs is still unclear [20,23,24]. While some studies suggested
that mTORC1 substrate phosphorylation increases with age, others observed that, in some tissues,
mTORC1 signaling decreases with age [23]. A possibility is that inhibition of mTORC1 in the highly
viable spermatozoa fraction slows aging by increasing autophagy, which helps clear damaged proteins
and organelles such as mitochondria, preventing damage to the cells. In fact, it was previously shown
that mTOR signaling inhibition leads to activation of autophagy in rat testes as a self-protective
mechanism of the cell in response to external stress [25]. Also, autophagy activation in spermatozoa
induced a significant increase in spermatozoa motility [26], which is in accordance with our findings.
On the contrary, when considering the entire spermatozoa population (including immotile, apoptotic,
and necrotic cells), all our findings support an active mTORC1 signaling pathway. The phosphorylation
of the autophagy machinery components by the mTORC1 complex compromises its function, which
limits the selective elimination of damaged and dangerous components to the cell, reducing longevity.
Reduced autophagy favors the accumulation of oxidized proteins or damaged mitochondria that
produce high levels of ROS, which in turn can explain the decline in spermatozoa motility, normal
morphology, and unfragmented cells observed in older men. In fact, autophagy inhibition was
previously shown to decrease spermatozoa motility and increased caspase 3 activation [26], which we
also observed in the total spermatozoa population of older men (Table 1). The role of mTOR signaling
pathway in spermatozoa is still unknown and, to our knowledge, this is the first time that mTOR
signaling was associated with aging in sperm cells. Ultimately, the importance of mTORC1 signaling
in spermatozoa aging likely reflects its unique capacity to regulate a variety of key cellular functions,
including autophagy and cell motility. Autophagy-related proteins were only recently shown to be
functionally active in human spermatozoa [26]. In testis, RPS6KB1 activity (a major substrate of
mTORC1) was linked to the actin cytoskeleton and, consequently, to cell motility [27].
When analyzing the total spermatozoa fractions, rather than a sperm subpopulation, it is important
to consider that distinct spermatozoa subpopulations will be present, including cells under adaptive
responses (e.g., activation of damage repair mechanisms), as well as apoptotic and necrotic cells.
The increased levels of activated TP53 (S15) and CASP3 (D175) in the total spermatozoa fraction of older
men, but not in the highly viable fraction, may reflect the contribution of the defective spermatozoa in
the activation of these apoptotic markers. CASP3 activity is associated with teratozoospermia and
asthenozoospermia, suggesting that nuclear, mitochondrial, and cytoskeletal abnormalities induce
CASP3 activation [28]. CASP3 was also shown to be increased in sperm from men with diabetes
type I [29]. Serine 15 is the primary target of the DNA damage response on the TP53 protein.
TP53 was previously reported to be upregulated in sperm from men with varicocele [30] and DNA
fragmentation [31].
In the total spermatozoa fractions of older men, we also observed an activation of the
mitogen-activated protein kinases (MAPKs). Several findings support the participation of the MAPK
pathway in germ cell apoptosis [32,33]. In mature spermatozoa, this pathway was associated with
capacitation and acrosome reaction [32,34]; however, due to conflicting findings, the role of MAPKs
remains uncertain. The MAPK pathway is responsible for the phosphorylation of the heat shock protein
HSPB1 (also known as HSP27). In fact, in the total spermatozoa fraction of older men, we observed
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increased levels of phosphorylated HSPB1. Increased HSPB1 expression and phosphorylation are
mostly associated with response to different stress stimuli and actin organization [35]. In spermatozoa,
increased levels of HSPB1 were previously associated with poor blastocyst development [36] and
sperm DNA fragmentation [37].
When analyzing the PPI network of the proteins identified in this study whose activity is
correlated with age and the data gathered from the literature search about the proteins that are up
and downregulated in older men, the proteins with a higher degree of connectivity were TP53, AKT1,
and MTOR. This further supports a key role for mTOR signaling in the spermatozoa aging process and
pinpoints a relevant role for TP53 in this process (Figure 3). TP53 has the potential to be a marker for
sperm quality in older men since, in addition to being a central hub in the network of sperm proteins
associated with age, it presents, among the proteins analyzed, the highest correlation with male age.
In the expanded PPI network, constructed by adding the interactors annotated in the Gene
Ontology category “aging” (Figure S2, Supplementary Materials), the most significant biological
processes were response to stress, apoptotic process, and MAPK cascade, further pinpointing the
potential role of these pathways in the spermatozoa aging process.
It was recently established that semen parameters do not change before 34 years old [9]. Other age
thresholds (i.e., 45 and 55 years old) were also reported for several basic semen parameters [38–40].
Our analysis revealed that a consistent increase in the levels of most signaling proteins analyzed in
total spermatozoa fractions appeared as soon as 27 years of age (Figure S1, Table S4, Supplementary
Materials). This threshold occurs prior to the ones established for basic semen parameters, which
suggests that alterations at the molecular level may occur earlier. Rising levels of ROS in semen were
reported in men over 40 years old, and ROS were suggested as the instrumental factor for incremental
sperm defects with aging [41]. Our analysis revealed alterations at the molecular level occurring before
this age threshold, which may indicate other possible mechanisms responsible for the age-dependent
decline in sperm quality.
The power of the study to determine age thresholds for the molecular parameters in the highly
motile/viable spermatozoa population was limited by the relatively small sample size in this group
(N = 30). Additionally, the participant age range was limited (18 to 47 years of age) and its distribution
differed in both cohorts. We cannot exclude that our findings are due to unmeasured confounders,
including lifestyle factors such as alcohol consumption, diet, exercise, and stress. Finally, further
studies concerning the total abundance of the sperm proteins identified as associated with male age
need to be performed.
This study was the first to associate the mTOR signaling pathway in human spermatozoa with
men’s age and to recognize the distinct activation status of this pathway in different spermatozoa
populations (Figures 1 and 3). Also, in older men, the total spermatozoa population presented increased
activity of apoptotic/stress markers (such TP53) and the MAPK pathway. Additionally, an age threshold
for changes in certain spermatozoa signaling parameters was established. Finally, a network of the
sperm proteins associated with male age was constructed and analyzed, which allowed supporting a
key role for the mTOR signaling in the spermatozoa aging process and which allowed recognizing
TP53 as a central player in this process (Figure 2).
Disclosing these molecular signatures of spermatozoa associated with aging is a further step in
the development of therapeutic intervention to counteract male subfertility/infertility associated with
male senescence.
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